Human TPMT (Thiopurine S-Methyltransferase) ELISA Kit (HUES03539)
- SKU:
- HUES03539
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- P51580
- Sensitivity:
- 1.88ng/mL
- Range:
- 3.13-200ng/mL
- ELISA Type:
- Sandwich
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cell Biology
Description
Human TPMT (Thiopurine S-Methyltransferase) ELISA Kit
The Human TPMT (Thiopurine S-Methyltransferase) ELISA Kit is designed for the precise measurement of TPMT levels in human serum, plasma, and cell culture supernatants. This kit boasts high sensitivity and specificity, ensuring dependable and consistent results, which makes it perfect for a variety of research purposes.TPMT is an essential enzyme that plays a key role in the metabolism of thiopurine drugs used to treat inflammatory bowel disease, autoimmune disorders, and leukemia. Variations in TPMT activity can impact drug efficacy and toxicity, making the measurement of TPMT levels crucial for personalized medicine and optimizing drug dosages.
By accurately quantifying TPMT levels, researchers can better understand drug metabolism, develop personalized treatment plans, and identify individuals at risk for drug-related complications. The Human TPMT ELISA Kit provides a reliable tool for studying TPMT activity and its implications in various disease states, ultimately aiding in the advancement of precision medicine.
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection Method: | Colormetric |
Detection Range: | 3.13-200 ng/mL |
Sensitivity: | 1.88 ng/mL |
Sample Volume Required Per Well: | 100µL |
Sample Type: | Serum, plasma and other biological fluids |
Specificity: | This kit recognizes Human TPMT in samples. No significant cross-reactivity or interference between Human TPMT and analogues was observed. |
This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TPMT. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TPMT and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TPMT, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by adding Stop Solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TPMT. The concentration of Human TPMT in samples can be calculated by comparing the OD of the samples to the standard curve.
UniProt Protein Function: | TPMT: Catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine. Defects in TPMT are the cause of thiopurine S- methyltransferase deficiency (TPMT deficiency). TPMT is an enzyme involved in the normal metabolic inactivation of thiopurine drugs. These drugs are generally used as immunosupressants or cytotoxic drugs and are prescribed for a variety of clinical conditions including leukemia, autoimmune disease and organ transplantation. Patients with intermediate or no TPMT activity are at risk of toxicity after receiving standard doses of thiopurine drugs and it is shown that inter-individual differences in response to these drugs are largely determined by genetic variation at the TPMT locus. Belongs to the methyltransferase superfamily. TPMT family. |
UniProt Protein Details: | Protein type:Xenobiotic Metabolism - drug metabolism - other enzymes; EC 2. 1. 1. 67; Methyltransferase Chromosomal Location of Human Ortholog: 6p22. 3 Cellular Component: cytosol Molecular Function:thiopurine S-methyltransferase activity Biological Process: methylation; xenobiotic metabolic process; nucleobase, nucleoside, nucleotide and nucleic acid metabolic process Disease: Thiopurine S-methyltransferase Deficiency |
NCBI Summary: | This gene encodes the enzyme that metabolizes thiopurine drugs via S-adenosyl-L-methionine as the S-methyl donor and S-adenosyl-L-homocysteine as a byproduct. Thiopurine drugs such as 6-mercaptopurine are used as chemotherapeutic agents. Genetic polymorphisms that affect this enzymatic activity are correlated with variations in sensitivity and toxicity to such drugs within individuals, causing thiopurine S-methyltransferase deficiency. Related pseudogenes have been identified on chromosomes 3, 18 and X. [provided by RefSeq, Aug 2014] |
UniProt Code: | P51580 |
NCBI GenInfo Identifier: | 1730006 |
NCBI Gene ID: | 7172 |
NCBI Accession: | P51580. 1 |
UniProt Secondary Accession: | P51580,O14806, O15423, O15424, O15425, O15426, O15515 O15548, O43213, Q5VUK6, Q9UBE6, Q9UBT8, |
UniProt Related Accession: | P51580 |
Molecular Weight: | 245 |
NCBI Full Name: | Thiopurine S-methyltransferase |
NCBI Synonym Full Names: | thiopurine S-methyltransferase |
NCBI Official Symbol: | TPMT |
NCBI Protein Information: | thiopurine S-methyltransferase; S-adenosyl-L-methionine:thiopurine S-methyltransferase |
UniProt Protein Name: | Thiopurine S-methyltransferase |
UniProt Synonym Protein Names: | Thiopurine methyltransferase |
UniProt Gene Name: | TPMT |
UniProt Entry Name: | TPMT_HUMAN |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (ng/mL) | O.D | Average | Corrected |
200 | 2.266 2.306 | 2.286 | 2.217 |
100 | 1.481 1.505 | 1.493 | 1.424 |
50 | 0.835 0.801 | 0.818 | 0.749 |
25 | 0.442 0.454 | 0.448 | 0.379 |
12.5 | 0.255 0.241 | 0.248 | 0.179 |
6.25 | 0.163 0.149 | 0.156 | 0.087 |
3.13 | 0.109 0.121 | 0.115 | 0.046 |
0 | 0.059 0.079 | 0.069 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human TPMT were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human TPMT were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 9.32 | 29.50 | 86.97 | 8.77 | 28.91 | 88.71 |
Standard deviation | 0.62 | 1.60 | 3.10 | 0.51 | 1.65 | 3.81 |
C V (%) | 6.65 | 5.42 | 3.56 | 5.82 | 5.71 | 4.29 |
Recovery
The recovery of Human TPMT spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 94-106 | 100 |
EDTA plasma (n=5) | 89-102 | 96 |
Cell culture media (n=5) | 93-107 | 100 |
Linearity
Samples were spiked with high concentrations of Human TPMT and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 96-111 | 98-110 | 95-109 |
Average (%) | 103 | 103 | 101 | |
1:4 | Range (%) | 88-104 | 82-94 | 88-101 |
Average (%) | 95 | 87 | 94 | |
1:8 | Range (%) | 90-101 | 79-90 | 86-99 |
Average (%) | 95 | 86 | 91 | |
1:16 | Range (%) | 95-108 | 82-93 | 83-95 |
Average (%) | 100 | 88 | 88 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
Stop Solution | 1 vial, 10 mL | 4°C |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100µl of standard solutions into the standard wells.
- Add 100µl of Sample / Standard dilution buffer into the control (zero) well.
- Add 100µl of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37°C.
- Aspirate the liquid from each well, do not wash. Immediately add 100µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37°C.
- Aspirate or decant the solution from the plate and add 350µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37°C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 90µL of Substrate Reagent to each well. Cover with a new plate seal and incubate forapproximately 15 min at 37°C. Protect the plate from light. Note: the reaction time can beshortened or extended according to the actual color change, but not by more than 30min.
- Add 50 µL of Stop Solution to each well. Note: Adding the stop solution should be done inthe same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm.